-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Monday's Intraday Session
Share
Listen to the news

Gainers

  • Agenus (NASDAQ:AGEN) shares increased by 95.8% to $6.56 during Monday's regular session. The market value of their outstanding shares is at $139.5 million.
  • Q32 Bio (NASDAQ:QTTB) stock rose 81.08% to $20.3. The company's market cap stands at $190.0 million.
  • Actuate Therapeutics (NASDAQ:ACTU) stock rose 22.31% to $1.48. The market value of their outstanding shares is at $28.9 million.
  • Alpha Compute (NASDAQ:ALP) stock increased by 19.07% to $0.28. The company's market cap stands at $5.6 million.
  • Accuray (NASDAQ:ARAY) shares rose 15.08% to $0.28. The company's market cap stands at $28.7 million.
  • Galectin Therapeutics (NASDAQ:GALT) stock moved upwards by 14.16% to $4.63. The market value of their outstanding shares is at $267.3 million.

Losers

  • BNB Plus (NASDAQ:BNBX) shares declined by 54.9% to $0.17 during Monday's regular session. The market value of their outstanding shares is at $2.7 million.
  • Matinas BioPharma Hldgs (AMEX:MTNB) stock fell 47.05% to $0.4. The company's market cap stands at $4.8 million.
  • BioVie (NASDAQ:BIVI) stock decreased by 27.32% to $1.65. The company's market cap stands at $17.1 million.
  • Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) shares declined by 22.3% to $0.09.
  • Apollomics (NASDAQ:APLM) stock fell 20.9% to $14.99. The company's market cap stands at $41.6 million.
  • Circle8 Group (NASDAQ:CIRC) shares decreased by 18.03% to $0.7. The market value of their outstanding shares is at $77.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending